2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
CNS
1
Conditions
Breast Neoplasms
4
Neoplasms
2
Multiple Myeloma
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myeloid, Acute
2
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Seminoma
1
Prostate Cancer Metastatic
1
Ovarian Neoplasms
1
Neutropenia
1
Lymphoma, B-Cell
1
Hodgkin Disease
1
Endodermal Sinus Tumor
1
Central Nervous System Neoplasms
1
Castrate Resistant Prostate Cancer
1
Interventions
Cisplatin
12
Etoposide
11
Carboplatin
9
Paclitaxel
7
Ifosfamide
7
Filgrastim
7
Bleomycin
6
Radiotherapy
5
Magnetic Resonance Spectroscopy
4
pegfilgrastim
3
Peripheral Blood Stem Cell Transplantation
3
liposomal amphotericin B
2
Therapeutics
2
Platinum
2
Ipilimumab
2
Imatinib Mesylate
2
Granulocyte Colony-Stimulating Factor
2
Cyclophosphamide
2
CTLA-4 Antigen
2
tremelimumab
1
sodium thiosulfate
1
sargramostim
1
lerisetron
1
ixabepilone
1
etoposide phosphate
1
durvalumab
1
cabozantinib
1
aldesleukin
1
Vinblastine
1
Thiotepa
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Seminoma
×
Lenograstim
×
Clear all
NCT00551122
2013-01-23
GemTIP
University of Southampton
Phase 1/2
Unknown
23 enrolled